Cargando…
Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies
Oxidation of low-density lipoprotein (LDL) has a key role in atherogenesis. Among the different models of oxidation that have been studied, the one using myeloperoxidase (MPO) is thought to be more physiopathologically relevant. Apolipoprotein B-100 is the unique protein of LDL and is the major targ...
Autores principales: | Delporte, Cédric, Van Antwerpen, Pierre, Vanhamme, Luc, Roumeguère, Thierry, Zouaoui Boudjeltia, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742028/ https://www.ncbi.nlm.nih.gov/pubmed/23983406 http://dx.doi.org/10.1155/2013/971579 |
Ejemplares similares
-
Myeloperoxidase-Dependent LDL Modifications in Bloodstream Are Mainly Predicted by Angiotensin II, Adiponectin, and Myeloperoxidase Activity: A Cross-Sectional Study in Men
por: Zouaoui Boudjeltia, Karim, et al.
Publicado: (2013) -
Mass Spectrometry for the Monitoring of Lipoprotein Oxidations by Myeloperoxidase in Cardiovascular Diseases
por: Coremans, Catherine, et al.
Publicado: (2021) -
Data on myeloperoxidase-oxidized low-density lipoproteins stimulation of cells to induce release of resolvin-D1
por: Dufour, Damien, et al.
Publicado: (2018) -
Effect of myeloperoxidase modified LDL on bovine and human aortic endothelial cells
por: El Samad, Ghadir, et al.
Publicado: (2019) -
Exposure of Endothelial Cells to Physiological Levels of Myeloperoxidase-Modified LDL Delays Pericellular Fibrinolysis
por: Zouaoui Boudjeltia, Karim, et al.
Publicado: (2012)